Cystic fibrosis transmembrane regulator (CFTR) ΔF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer

Gut

Volumn 48, Issue 1, 2001, Pages 70-74

  Malats, N ^a   Casals, T ^b   Porta, M ^a   Guarner, L ^c   Estivill, X ^b   Real, F X ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

5T allele; Chronic pancreatitis; Cystic fibrosis transmembrane regulator gene; Genetic susceptibility; Pancreatic cancer; F508 mutation

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CHRONIC PANCREATITIS; CLINICAL TRIAL; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS CANCER; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 81355156452     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.1.70     Document Type: Article

References (29)

1. Localization of the cystic fibrosis transmembrane regulator in the pancreas
2. Pathology of cystic fibrosis: Review of the literature and comparison with 146 autopsied cases
3. The pancreas in cystic fibrosis
4. Complexity in a monogenic disease
5. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens
6. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis
7. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis
8. High heterogeneity for cystic fibrosis in Spanish families: 75 Mutations account for 90% of chromosomes
9. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
10. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
11. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
12. The risk of cancer among patients with cystic fibrosis
13. Pancreatitis and the risk of pancreatic cancer
14. Pancreatic cancer
15. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer
16. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology
17. Learning from case-reports: Diagnostic issues in an epidemiologic study on pancreatic cancer
18. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer
19. Natural histories of alcoholic and idiopathic chronic pancreatitis
20. Medical conditions in patients with pancreatic and biliary diseases: Validity and agreement between data from questionnaires and medical records
21. Risk of pancreatic cancer and occupational exposures in Spain
22. Ki-ras mutations in exocrine pancreatic cancer: Association with clinico-pathological characteristics and with tobacco and alcohol consumption
23. Rapid nonradioactive detection of the major cystic fibrosis mutation
24. A mutation in CFTR produces different phenotypes depending on chromosomal background
25. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium
26. Correction: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
27. Missense mutations in the cystic fibrosis gene in adult patients with asthma